Changes in prostate-specific antigen midway through salvage radiotherapy may be associated with long-term outcomes

ConclusionsPSA changes by the midpoint of SRT predict long-term prostate cancer control with increases in PSA associated with decreased freedom from disease progression.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research